Belatacept Completed Phase 4 Trials for Kidney Transplantation Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care4
clinicaltrials.gov IdentifierTitleDrugs
NCT02560558Bela 8 Week Dosing